Medical Equipment

Ventracor (ASX: VCR) Announce 150 VentrAssist Implants Worldwide

🕔10/5/2007 4:01:23 PM

Ventracor (ASX: VCR) today announced the 150th implant of the VentrAssist Left Ventricular Assist Device (LVAD).

Read Full Article

Ventracor Announces FY2007 Results And Strong Revenue Growth on 64 LVAD Implants

🕔8/16/2007 9:40:38 PM

Ventracor (ASX: VCR) today announced its results for the year ending 30 June 2007, with increasing sales revenues in the US, Europe and Australasia of $4.9m (2006;$1.1m) from 64 implants, and a net loss of $36.5m (2006;$30m).

Read Full Article

Heartware Announce Clinical Trial Update

🕔7/13/2007 1:46:04 PM

Following significant shareholder enquiry, the Company provides an update of the status of the international clinical trial currently underway for HeartWare's (ASX: HTW) HVAD TM Left Ventricular Assist Device.

Read Full Article

Ellex Medical Lasers Limited ASX: ELX - Raises $5.5 million through Placement - Mr Peter Falzon, CEO

🕔6/26/2007 9:50:00 AM

Ellex Medical Lasers Limited (ASX: ELX) - Raises $5.5 million through Placement - Mr Peter Falzon, CEO; Boardroomradio is pleased to announce that Ellex Medical Lasers Limited (ASX: ELX) has published an audio file.

Read Full Article

Ventracor Launch US Pivotal Trial of VentrAssist

🕔6/6/2007 10:32:49 AM

Ventracor (ASX: VCR)(ADR: VTCRY) today announced the first patient implant in the US Bridge to Transplant (BTT) pivotal trial of the VentrAssist(tm) left ventricular assist device (LVAD) at the Medical University of Minnesota, in Minneapolis.

Read Full Article

Ventracor; Growing Global Momentum Results in Strong Revenue Growth

🕔6/5/2007 12:47:29 PM

Ventracor (ASX: VCR)(ADR: VTCRY) yesterday confirmed growing momentum in Europe and the USA, with increases in the number of VentrAssist(tm) Left Ventricular Assist Device (LVAD) implants, resulting in record monthly sales revenue.

Read Full Article

Ventracor's Clinical Trial Programme In US Gaining Traction

🕔5/29/2007 9:28:20 PM

Ventracor (ASX: VCR) (ADR: VTCRY) is about to commence two major clinical trials in the US after the company successfully completed a Feasibility Trial. The first is a Bridge to Transplant (BTT) Pivotal Trial for patients on the transplant list; the FDA recently approved the start of this trial.

Read Full Article